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Abstract 
Background: Bacterial production of natively folded heterologous proteins by secretion to the extracellular space 
can improve protein production by simplifying purification and enabling continuous processing. In a typical bacterial 
protein production process, the protein of interest accumulates in the cytoplasm of the cell, requiring cellular lysis and 
extensive purification to separate the desired protein from other cellular constituents. The type III secretion system 
of Gram‑negative bacteria is used to secrete proteins from the cytosol to the extracellular space in one step, but 
proteins must unfold during translocation, necessitating the folding of secreted proteins in the extracellular space for 
an efficient production process. We evaluated type III secretion as a protein production strategy by characterizing and 
quantifying the extent of correct folding after secretion.
Results: We probed correct folding by assaying the function after secretion of two enzymes—beta‑lactamase and 
alkaline phosphatase—and one single‑chain variable fragment of an antibody. Secreted proteins are correctly folded 
and functional after unfolding, secretion, and refolding in the extracellular space. Furthermore, structural and chemi‑
cal features required for protein function, such as multimerization and disulfide bond formation, are evident in the 
secreted protein samples. Finally, the concentration of NaCl in the culture media affects the folding efficiency of 
secreted proteins in a protein‑specific manner.
Conclusions: In the extracellular space, secreted proteins are able to fold to active conformations, which entails 
post‑translational modifications including: folding, multimerization, acquisition of metal ion cofactors, and formation 
of disulfide bonds. Further, different proteins have different propensities to refold in the extracellular space and are 
sensitive to the chemical environment in the extracellular space. Our results reveal strategies to control the secretion 
and correct folding of diverse target proteins during bacterial cell culture.
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Background
Heterologous protein production is used to make protein 
products, such as therapeutics and industrial enzymes, 
and enables researchers to study proteins that would oth-
erwise be difficult to isolate from their native source. In 
order for a protein to perform its function, the protein 
must adopt a three-dimensional structure that allows 
for proper function. When producing a heterologous 
protein, it is desired to maximize both product titer and 
proper folding of the protein of interest. Secretion of het-
erologous proteins to the extracellular space holds sev-
eral advantages over intracellular production: proteins 
accumulate outside the cell, limiting cytotoxicity associ-
ated with intracellular accumulation; secretion serves as 
a first step of purification, as the cell selectively secretes 
proteins to the extracellular space; and lysis of the pro-
duction organism is not required, enabling continuous 
protein production [1, 2]. Cytosolic accumulation also 
may result in aggregation of the protein of interest into 
inclusion bodies. The insoluble inclusion body is then 
dissolved and refolded in dilute solution in vitro, a diffi-
cult process that results in product losses [3]. Bacteria are 
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often used as a cellular host for protein production due to 
their fast growth, high protein production capacity, and 
inexpensive culture cost. However, not all proteins are 
efficiently secreted by bacteria [1].
The type III secretion system (T3SS) is a protein 
secretion machine found in Gram-negative patho-
genic bacteria. This multimeric heteroprotein structure 
is characterized by a long passageway that is 2–3  nm 
in internal diameter, termed the needle [4]. Given the 
diameter of a typical folded protein, considerable unfold-
ing of the protein is required in order to fit through the 
needle. It is hypothesized that only secondary structures 
could exist in the secreted protein during translocation. 
Indeed, cryo-electron microscopy of secretion suggests 
that proteins are fully linearized before being ejected 
into the extracellular space [5]. Proteins secreted by a 
T3SS have been previously shown to adopt a native con-
formation after secretion, both in the extracellular space 
and when delivered to the cytoplasm of a neighboring 
cell [6–8].
The constraints of this system present a unique condi-
tion for protein folding. Proteins are secreted by the T3SS 
at a rate of 103–104 amino acids per second per appara-
tus [9, 10] (about 1–10 proteins per second) and must 
be unfolded in order to pass through the T3SS [5]. Thus, 
proteins are released rapidly into the extracellular space 
in an unfolded and extended confirmation, in contrast 
to the mechanism of co-translational folding. Addition-
ally, the extracellular space has a much lower macro-
molecule concentration compared to inside the cell [11]. 
As a result, protein folding post-secretion may resem-
ble in  vitro refolding in dilute solution. By capitalizing 
on this feature of protein folding and coupling produc-
tion with secretion, this T3SS-based approach may hold 
advantages over industrial approaches that are based on 
inclusion body formation that requires a separate refold-
ing step [12].
In this study, we tested the biochemical requirements 
for protein function to understand protein folding fol-
lowing secretion by the T3SS. We used protein function 
(e.g., enzymatic activity or antigen binding) as a proxy 
for folding. We investigated the ability two enzymes 
(beta-lactamase and alkaline phosphatase) and one 
single-chain variable fragment (scFv) of an antibody to 
adopt an active conformation after secretion. We found 
in all cases that protein secretion to the extracellu-
lar space allows the production of functional, correctly 
folded protein product. Moreover, we found that the 
concentration of sodium chloride in the culture medium 
could affect both secreted protein titer and the fraction 
of secreted proteins that are correctly folded, allowing 
for simultaneous optimization of both protein titer and 
folding.
Results
Secreted proteins are functional after secretion
Beta-lactamase (EC:3.5.2.6, class A) is a monomeric 
enzyme that forms one intrachain disulfide bond, but is 
not required for activity [13]. No cofactors are required 
for activity [14]. We previously reported that the enzyme 
beta-lactamase adopts a catalytically active confor-
mation after secretion by the T3SS [6]. We confirmed 
that beta-lactamase was indeed active in the extracel-
lular space after secretion by the T3SS, and found that 
enzymatic activity in the extracellular space was both 
enzyme- and secretion-dependent (Fig.  1a). No secre-
tion or activity was detected when secretion was pre-
vented by deletion of the prgI gene, which codes for an 
essential component of the SPI-1 T3SS [15]. No activity 
was detected when the catalytic site of the enzyme was 
knocked out (ST71TS) [16], though the protein was still 
secreted. These results indicate that detected activity in 
the extracellular space was due to a catalytically active 
beta-lactamase. We mutated the two cysteine residues in 
beta-lactamase to serine to prevent disulfide bond for-
mation. Both mutant enzymes were secreted, and the 
C121S mutation resulted in a catalytic activity similar 
to the wild type. Interestingly, the C75S mutation was 
not catalytically active, in contrast to previous reports 
in the literature [13]. Differences in N- and C-terminal 
modification may explain this difference—our secreted 
beta-lactamase bears a substantial N-terminal secretion 
signal and C-terminal epitopes that may affect the essen-
tiality of Cys75.
The enzyme alkaline phosphatase (EC 3.1.3.1, isozyme 
1) requires the acquisition of two Zn2+ and one Mg2+ 
cofactors, dimerization, and the formation of two intra-
chain disulfide bonds for catalytic activity [17]. Catalytic 
activity in the extracellular space was detected, indicat-
ing that alkaline phosphatase folded and satisfied all 
structural requirements for activity in the extracellular 
space (Fig.  1b). No secretion or activity was detected 
when secretion was prevented by deletion of the prgI 
gene, and no activity was detected when the catalytic site 
of is knocked out (S102A) [18], though the protein was 
still secreted. Systematic mutation of each of the four 
cysteines to serine to prevent disulfide bond formation 
resulted in secreted but catalytically inactive enzyme. In 
addition, no activity was detected after chemical reduc-
tion of wild type alkaline phosphatase with 10% v/v 
2-mercaptoethanol. Further, no activity was detected in 
a monomeric alkaline phosphatase mutant (T60R) [19], 
though this mutant protein was still secreted. Together, 
these data indicate that alkaline phosphatase folds into a 
catalytically active conformation, including the correct 
formation of disulfide bonds, in the extracellular space 
after secretion by the SPI-1 T3SS.
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A single-chain variable fragment (scFv) of an antibody is 
a monomeric protein that forms, but does not necessarily 
require, two intrachain disulfide bonds. 14B7* is an scFv 
of a mouse IgG antibody that binds to the protective anti-
gen (PA) of the anthrax toxin [20, 21]. Binding of secreted 
14B7* to PA was detected by enzyme-linked immuno-
sorbent assay (ELISA) (Fig.  1c). No secretion or activ-
ity was detected when secretion is prevented by deletion 
of the prgI gene. Systematic mutation of each of the four 
cysteines to serine to prevent disulfide bond formation 
resulted in secretion and antigen binding, though each of 
the four mutants exhibited lower binding than wild type. 
Chemical reduction of the wild type 14B7* secreted sam-
ple with 10% 2-mercaptoethanol did not affect binding 
activity, suggesting that disulfide bonds are not essential 
























































































































Fig. 1 Secreted proteins adopt functional conformations. Activity or ELISA signal is given for samples analyzed from the culture supernatant. 
Genetic modifications described are with respect to the mature native protein sequence of the POI in the fusion. All proteins are of the format SptP‑
POI‑2xFLAG‑6xHIS. Results are plotted for the POIs. a Beta‑lactamase (Bla). b Alkaline phosphatase (PhoA). c Single chain variable fragment against 
anthrax protective antigen (14B7*). The mean is plotted from three biological replicate experiments and the error bars represent one standard 
deviation. Western blots are representative of the samples analyzed in the functional assays
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Secreted proteins form disulfide bonds
The presence of disulfide bonds in secreted proteins was 
confirmed by selective cysteine alkylation with the rea-
gent 4′-acetamido-4′-maleimidylstilbene-2,2′-disulfonic 
acid (AMS). AMS selectively adds to free thiols, adding 
~500  Da of mass with each addition. It will not cova-
lently modify cysteines that participate in a disulfide 
bond. Reduction of the protein sample with tris(2-car-
boxyethyl)phosphine (TCEP) will reduce disulfide bonds 
and convert all cysteines to the free thiol form. Thus, 
we can observe the disulfide bond state of a protein by 
detecting changes in molecular weight resulting from 
redox-dependent protein modification by AMS [22]. 
Greater cysteine modification will result in a protein that 
migrates more slowly in a denaturing polyacrylamide 
gel. For all proteins tested, the N-terminal SptP secre-
tion signal sequence contains a cysteine residue at posi-
tion 112 that is not expected to participate in a disulfide 
bond and is thus a free thiol. Indeed, a shift in migration 
was detected when all proteins are modified with AMS 
without TCEP pretreatment, indicating that the cysteine 
in the SptP secretion signal sequence is modified (Fig. 2, 
lane 3).
Disulfide bonds were detected in beta-lactamase 
(Fig.  2a). This protein contains one intrachain disulfide 
bond in the native protein, giving a total of three cysteine 
residues in the fusion protein. An increase in apparent 
molecular weight was observed when the protein was 
modified with AMS after TCEP pretreatment, indicat-
ing that the protein contained a disulfide bond in the 
extracellular space. Disulfide bonds were also detected 
in both alkaline phosphatase and the 14B7* scFv (Fig. 2b, 
c). Both of these proteins contain two intrachain disulfide 
bonds in the native protein, giving a total of five cysteine 
residues in the fusion protein. When the sample was 
pretreated with TCEP before modification with AMS, 
a further increase in apparent molecular weight was 
observed, indicating that disulfide bonds were present in 
the secreted protein.
Specific activity of secreted enzymes is affected by salt 
concentration in growth medium
Activity of the secreted enzymes was compared with 
enzyme purified from the cytosol. While activity of the 
secreted enzymes was detected as shown in Fig. 1, it was 
not clear what fraction of the secreted enzymes were 
active. We define the parameter ffold as the fraction of 
functional secreted protein, relative to the same protein 
fusion purified from the cytoplasm. Briefly, we assume 
that secreted enzymes that are folded are also active and 
catalyze reactions with rate kcat, while misfolded secreted 
enzymes do not contribute to catalysis. The sample thus 
catalyzes reaction with an apparent rate constant, kappcat , 
that is less than or equal to kcat (see Additional file 1 sec-
tion for a thorough description of the ffold parameter and 
the apparent rate constant kappcat ).
Beta-lactamase and alkaline phosphatase were purified 
from the cytosol and the enzyme concentration, [E]T, and 
the kinetic parameters KM, k
app
cat , and Vmax were calculated 
for each sample. In addition, the same kinetic parameters 
were calculated for secreted enzyme (Table 1). This anal-
ysis was first performed in standard production media 











































Fig. 2 Western blots of secreted fusion protein samples subjected 
to the selective alkylation procedure separated by SDS‑PAGE. All 
proteins are of the format SptP‑POI‑2xFLAG‑6xHIS. Representative 
images are presented from a western blot for the POIs. a Bla. b PhoA. 
c 14B7*
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The fraction of secreted beta-lactamase enzymes that 
are active was 15 ± 2%, relative to the purified form. The 
kinetic parameters KM and k
app
cat  of the purified beta-lacta-
mase fusion compared well with published values for the 
wild type enzyme for the nitrocefin substrate (110  µM 
and 900 s−1, respectively) [23]. No statistically significant 
difference in the value of KM was found between puri-
fied and secreted beta-lactamase fusion. However, the 
secreted and purified forms of beta-lactamase signifi-
cantly differed in the calculated apparent rate constant, 
k
app
cat  (p < 0.05), suggesting a folding defect in the secreted 
enzyme, relative to the enzyme purified from the cell.
The fraction of secreted alkaline phosphatase enzymes 
that are active was 85  ±  10%, relative to the purified 
form. Both kinetic parameters, KM and k
app
cat , of the puri-
fied alkaline phosphatase fusion were significantly differ-
ent from the published values for the wild type enzyme 
for the para-nitrophenyl phosphate substrate (35 ± 5 µM 
and 176  ±  6  s−1, respectively) [24]. It should be noted 
that these reported kinetic parameters reported by 
Wojciechowski and Kantrowitz were calculated for reac-
tions performed at 25  °C in a Tris-buffered solution, 
while all reactions with alkaline phosphatase in this study 
were conducted at 37 °C in LB media, prohibiting a direct 
comparison of the values. No statistically significant dif-
ferences in the values of KM and k
app
cat  were found between 
purified and secreted alkaline phosphatase fusion. Thus, 
the activity of the alkaline phosphatase fusion studied in 
this work did not experience a significant folding defect 
after secretion, compared to protein purified from solu-
ble cytosolic fraction. It should be noted that while the 
value of KM for the secreted and purified samples was not 
statistically significantly different, the large difference in 
KM between the samples may indicate that the folding of 
alkaline phosphatase is not well described by our simple 
two-state model (see Additional file 1 section for details 
on two-state model).
We attempted to increase the parameter ffold by chang-
ing culturing conditions. By changing the components in 
the growth medium, we hypothesized that the folding of 
secreted protein could be modulated. The ionic strength 
of a solution is known to affect protein folding, likely 
through charge–charge interactions [25]. The concentra-
tion of NaCl in the growth medium was varied between 
5 and 17 g L−1 (0.09 and 0.3 M, respectively). The activ-
ity was then calculated using activity assays and quantita-
tive western blotting, as above. Interestingly, the activity 
of beta-lactamase at saturating concentrations of sub-
strate increased with NaCl concentration in the growth 
medium. This effect can be attributed in part to the fact 
that secreted protein titer increased monotonically with 
increasing [NaCl] (Fig.  3a.i). However, importantly, the 
increased activity in Fig. 3a.i was due to both increased 
enzyme concentration and increased ffold (Fig. 3a.ii). Fur-
ther, the calculated value of KM for secreted beta-lacta-
mase was not significantly different between the three 
media conditions tested (Fig. 3a.iii).
The effect of NaCl in the growth media had an opposite 
effect on alkaline phosphatase. No change was observed 
in secreted protein titer or activity at saturating concen-
trations of substrate (Fig. 3b.i). The value of ffold did not 
change at low concentrations of NaCl but decreased at 
the highest salt concentration (Fig. 3b.ii). The calculated 
value of KM for secreted alkaline phosphatase was not 
significantly different between the three conditions tested 
(Fig. 3b.iii).
Discussion
Pure and correctly folded protein is desired when pro-
ducing a heterologous protein. Production of heter-
ologous proteins via secretion to the extracellular space 
holds many advantages over intracellular accumulation: 
purification is simplified; cytotoxicity is alleviated; and 
cell lysis is not required [1, 2]. The production and secre-
tion of heterologous proteins can be achieved using the 
T3SS of various Gram-negative bacteria [7–9, 26, 27]. 
However, the mechanism of protein secretion requires an 
unfolding event during translocation [5]. For this produc-
tion strategy to be effective, the protein should fold into a 
functional conformation after secretion. This event must 
occur in the extracellular space, a region of the cell cul-
ture thought to be devoid of molecular chaperones that 
assist in protein folding. By testing for protein function, 
the folded state of the protein is probed, as only folded 
proteins are expected to be functionally active. The pro-
tein function assays are sensitive enough to give infor-
mation on the folded state of the protein of interest in a 
heterogeneous, dilute protein mixture.
Previous studies have demonstrated the ability of het-
erologous proteins secreted by a T3SS to adopt active 
conformations [6–8]. In this study, we investigated the 
ability of secreted proteins with different chemical and 
structural requirements to adopt active conformations. 
Table 1 Analysis of  refolding efficiency of  secreted 
enzyme in  the culture supernatant, relative to  purified, 
soluble cellular enzyme
Uncertainty is given as the standard error and is propagated for the ffold 
calculation. All experiments were performed three times in biological replicate. 
Parameters for secreted samples were calculated for samples generated in LB 
media with 5 g L−1 NaCl
Secreted Purified
Protein kappcat  (s
−1) KM (µM) kappcat  (s
−1) KM (µM) ffold
Bla 38 ± 4 28 ± 11 248 ± 11 42 ± 6 0.15 ± 0.02
PhoA 22 ± 2 100 ± 40 26 ± 2 230 ± 80 0.85 ± 0.10
Page 6 of 10Metcalf et al. Microb Cell Fact  (2016) 15:213 
The enzyme beta-lactamase folds into a catalytically 
active tertiary structure (Fig.  1a). The enzyme alkaline 
phosphatase adopts a catalytically active tertiary struc-
ture, forms a dimer and two intrachain disulfide bonds, 
and acquires one Mg2+ and two Zn2+ ions per chain 
(Fig.  1b). The scFv 14B7* folds into a tertiary structure 
that permits antigen binding (Fig. 1c). These data demon-
strate that proteins can adopt active confirmations after 
secretion. Furthermore, in the extracellular space—an 
area thought to be devoid of folding chaperones—forma-
tion of disulfide bonds, multimerization, and acquisition 
of metal ion cofactors can still occur. We hypothesize 
that these interactions occur spontaneously in the extra-
cellular space. It is unlikely that post-translational modi-
fications are achieved inside the cell before secretion, 
owing to the limited conformations allowed by the type 
III secretion system lumen. The cultures are grown aero-
bically, and it is likely that the oxidizing environment of 
the culture medium allows for disulfide bond formation. 
It is not clear, however, what molecular species, if any, are 
involved in disulfide bond formation. Dissolved oxygen 
and/or other components of the growth media may be 
involved in disulfide bond formation. Further, the growth 
media is not chemically defined and likely contains trace 
metals for secreted proteins to sequester. Nonetheless, it 
is surprising that these proteins are able to adopt active 
conformations in the extracellular space after secretion.
A comparison of the specific activity of secreted and 
purified cellular enzyme was performed to compare the 
fraction of secreted proteins that adopt active confor-
mations in the extracellular space. Secreted enzyme that 
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Fig. 3 NaCl concentration in media affects secreted protein titer and folding efficiency. Both proteins studied are in the fusion format SptP‑POI‑
2xFLAG‑6xHIS. For all plots, unless specified, the mean of three biological replicates is plotted, except where noted by the symbol * to indicate two 
biological replicates. Error bars represent one standard deviation, unless noted. a i Plot of raw activity of secreted Bla as a function of growth media 
with representative western blot of analyzed samples. ii Plot of ffold for secreted Bla as a function of growth media. iii Plot of KM for secreted Bla as 
a function of growth media. Error bars represent the standard error. b. i Plot of raw activity of secreted PhoA as a function of growth media with 
representative western blot of analyzed samples. ii Plot of ffold for secreted PhoA as a function of growth media. iii Plot of KM for secreted PhoA as a 
function of growth media. Error bars represent the standard error
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constant, kappcat . Indeed, beta-lactamase had a lower value 
of kappcat  in the secreted sample, compared to the puri-
fied protein (Table 1). This suggests that only a fraction 
of the secreted enzyme adopts an active conformation 
after secretion. Extending this reasoning, the percent-
age of secreted beta-lactamase that is active is 15 ±  2% 
(Table 1). We speculate that this is due to misfolding or 
aggregation. Increasing the ionic strength of a solution 
has been shown to increase the thermodynamic stabil-
ity of a folded monomeric protein [25], increasing the 
concentration of NaCl in the growth medium from 5 
to 17 g L−1 increased ffold of secreted beta-lactamase by 
almost threefold (Fig. 3a.ii). This indicates that the abil-
ity of the secreted protein to adopt an active conforma-
tion after secretion may be dependent on the chemical 
environment in which it folds. Secreted alkaline phos-
phatase had a kappcat  value similar to the purified sample, 
such that the percentage of folded enzyme is 85 ±  10% 
for the 5 g L−1 NaCl sample (Table 1). This indicates that 
the fraction of folding for secreted alkaline phosphatase 
is similar to the folding when the enzyme is purified from 
the soluble cellular fraction following cytosolic expres-
sion. Increasing the concentration of NaCl from 5 to 
10 g L−1 in the culture medium did not increase the value 
of ffold (Fig. 3b.ii). However, the value of ffold decreased at 
the highest media NaCl concentration. This effect could 
be due to increased charge screening at high solution 
ionic strength, as charge–charge interactions are known 
to be important in dimerization of alkaline phosphatase 
[19, 28].
Understanding protein folding after secretion is impor-
tant for improving protein production. Large-scale pro-
tein production often involves production of the protein 
of interest in inclusion bodies, which are then solubilized 
and refolded. Parallels exist between protein folding in 
the extracellular space and inclusion body solubiliza-
tion followed by protein refolding in vitro. In an in vitro 
refolding procedure, the inclusion body is solubilized 
in a high concentration solution of a chaotrope, such as 
guanidinium chloride. This also unfolds the proteins in 
the inclusion body. The solution is then diluted to allow 
for proteins to fold into a native conformation. Dilution 
decreases the concentration of protein in solution in 
addition to decreasing the concentration of chaotrope. 
The lower concentration of protein in solution improves 
protein refolding, as each chain is less likely to form inter-
chain aggregates. Secretion of protein to the extracellular 
space mimics this process, as the extracellular space also 
has a lower protein concentration, relative to inside the 
bacterial cell. The needle structure of the T3SS extends 
~50  nm from the outer membrane [29], potentially 
beyond any extracellular cellular structures, such as the 
lipopolysaccharide layer. Thus, we speculate that proteins 
secreted by the T3SS to the extracellular space will expe-
rience a folding environment that, as in in  vitro refold-
ing, can be tailored to increase the folding of the secreted 
protein. In addition to allowing the facile production of 
correctly folded heterologous protein in the supernatant 
of bacterial culture, protein secretion by the T3SS offers 
a unique condition to study protein folding. Refolding of 
proteins after secretion may access different folding tra-
jectories than found in co-translational or in vitro folding 
conditions. Given the rate and directionality of secretion, 
proteins may fold in a unique vectorial folding pathway. 
Further, the unfolded conformations that are accessible to 
the protein during secretion are likely constrained, which 
in turn may change the conformations that are accessible 
after secretion. We anticipate that this system will pro-
vide a unique folding environment for future study.
Conclusions
Production of heterologous proteins in bacteria is 
improved using a secretion strategy. In this study, the 
T3SS of Salmonella enterica was used to secrete pro-
teins to the extracellular space. A folded protein product 
in the extracellular space is desired, but the T3SS secre-
tion mechanism requires proteins to be unfolded during 
translocation. We characterized folding of secreted pro-
teins by quantifying protein function, either by enzymatic 
activity or antigen binding. Indeed, the three secreted 
proteins in this study adopt a functional confirmations 
after secretion to the extracellular space. However, only 
a fraction of secreted proteins are functional, between 
10 and 85%. Media composition was used to modify the 
chemical environment in the extracellular space. Increas-
ing the concentration of NaCl in the culture medium 
had a protein-specific effect on the ability of a secreted 
protein to adopt an active conformation in the extracel-
lular space. Further understanding of how chemical and 
genetic variables control the folding of secreted proteins 
will be important for process development of bacterial 
strains for production of secreted proteins. An improved 
production process achieves secretion a protein at high 
titer to the extracellular space and that spontaneously 
adopts a functional conformation. This would simplify 
purification and not require refolding unit operations.
Methods
Strains and growth conditions
All S. enterica experiments used derivatives of the 
SL1344 strain [30]. The prgI deletion strain was described 
by Metcalf et  al. [6]. All strains were grown from colo-
nies from fresh transformations or fresh streaks from fro-
zen stock in lysogeny broth (LB-Lennox, LB-L) (10 g L−1 
tryptone, 5  g  L−1 yeast extract, and 5  g  L−1 NaCl) 
(VWR #EM1.00547.5007) with appropriate antibiotics 
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(34 µg mL−1 chloramphenicol and/or 50 µg mL−1 kana-
mycin) for 12–16  h at 37  °C and 225  rpm in an orbital 
shaker overnight. Overnight cultures were subcultured 
into fresh LB-L media supplemented with 100  µM iso-
propyl β-d-1-thiogalactopyranoside (IPTG) and the 
appropriate antibiotics. All culturing steps were per-
formed in 24-well blocks (Axygen).
Salmonella enterica strains were transformed with 
the plasmids listed in Additional file  1: Table S1 using 
electroporation. All experiments were performed using 
a two-plasmid system, with the upregulation vector 
(PlacUV5 hilA), as reported by Metcalf et al. [6], in addition 
to the export vector that carried the gene coding for the 
protein of interest [26]. Controlled overexpression of hilA 
allows for controlled expression of genes coding for both 
the secretion apparatus and the protein of interest [6].
DNA manipulations
PCR was performed with Pfu DNA polymerase and the 
primers listed in Additional file  1: Table S2. Restric-
tion enzymes and ligase (NEB) were used according to 
the manufacturer’s instructions. For all cloning, E. coli 
DH10B cells were used. Mutations to bla and phoA are 
specified with respect to the full-length mature wild type 
protein. Mutations to 14b7* are specified with respect 
to the order of cysteines, from amino to carboxy termi-
nus, in the antibody fusion gene and does not include the 
cysteine in the N-terminal SptP signal sequence. The bla 
gene was amplified from the plasmid pTrc99A [31]. The 
phoA gene was amplified from E. coli MG1655. The 14b7* 
gene was amplified from the plasmid pFLAG-APEx 
14B7* (gift from the Georgiou lab).
Protein separation and western blotting
Samples were separated by SDS-PAGE. Proteins were 
transferred to a polyvinylidene fluoride (Millipore) 
membrane for chemiluminescence detection, using the 
TransBlot SD unit (Bio-Rad). Membranes were interro-
gated with Mouse anti-FLAG antibodies per manufac-
turer’s instructions (Sigma). A secondary labeling step 
was carried out with Goat anti-Mouse IgG (H + L), HRP 
conjugate antibodies, per manufacturer’s instructions 
(Thermo). Bands were visualized with west-pico or west-
femto chemiluminescent substrate (Thermo) and imaged 
with a ChemiDoc XRS + unit (Bio-Rad).
Protein purification
Culture homogenate was purified using a His Gravi-
Trap column (GE Healthcare # 11-0033-99). Eluted pro-
tein sample was separated by SDS-PAGE, stained with 
Coomassie G-250, and quantified using densitometry 
relative to a bovine serum albumin standard (Thermo). 
Purified protein samples were diluted in LB-L and stored 
at 4 °C for enzyme activity assays.
Protein quantification
Supernatant samples were harvested 8 h after subculture. 
Supernatant samples were harvested from the cell cul-
ture by two sequential centrifugation steps of 2272×g for 
10 min, 4× Laemmli buffer was added to each sample for 
a final concentration of Laemmli buffer of 1×, and boiled 
for 95 °C for 5 min. Purified protein samples were used to 
create four standards that were included with each blot 
to construct a standard curve. Samples were separated 
by SDS-PAGE and transferred to a polyvinylidene fluo-
ride (Millipore). A linear least-squares regression of the 
standard samples were used to calculate the concentra-
tion of each supernatant sample.
Beta‑lactamase activity assay
Samples were grown overnight in LB-L media, then sub-
cultured 1:100 in LB-L media and grown for 8 h at 37 °C 
and 225 rpm. The cultures were pelleted by one centrifu-
gation step of 2272×g for 10 min and the supernatant was 
passed through a 0.45 μm filter. Samples were then sub-
jected to a nitrocefin hydrolysis assay, per the substrate 
vendor (Sigma). 100  μL of reaction buffer (0.1  M phos-
phate, 1 mM ethylenediaminetetraacetic acid, 50 g mL−1 
nitrocefin (EMD Millipore), 0.5% dimethyl sulfoxide, 
pH 7) was mixed with 10  μL culture supernatant and 
the absorbance at 486  nm was observed over time. The 
reaction was performed in a disposable UV-Transparent 
cuvette (BrandTech, part# 759215) without stirring at 
37 °C. The absorbance at 486 nm was measured every 5 s 
for 60  s with a UV–Vis spectrophotometer (Nanodrop, 
part# 2000c). The reaction was linear for the first 40 s of 
all reactions tested and the change in the absorbance as 
a function of time was determined using a linear least-
squares fit. The initial reaction velocity was calculated 
using an extinction coefficient of 20,500  M−1  cm−1, as 
specified by the vendor. The experiment was performed 
on different days in biological triplicate. Error bars repre-
sent one standard deviation.
Alkaline phosphatase activity assay
Samples were grown overnight in LB-L media, then sub-
cultured 1:100 in LB-L media and grown for 8 h at 37 °C 
and 225  rpm. The cultures were pelleted by one cen-
trifugation step of 2272×g for 10  min and the superna-
tant was passed through a 0.45  μm filter. Samples were 
then subjected to a para-nitrophenyl phosphate assay, 
modified from Glasgow et  al. [32]. Briefly, supernatant 
samples were mixed with the appropriate volume of 
1 M Tris (base), pH 8.0 and 0.4 w/w% para-nitrophenyl 
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phosphate. For endpoint assays, multiple equal-volume 
reactions were performed simultaneously in a 96-well 
microtiter plate and incubated at 37  °C without shaking 
for at least 1  h. The absorbance at 405  nm of each well 
was measured using a Synergy HTX Multi-Mode Reader 
spectrophotometer (Bio-Tek). For kinetic assays, the 
reaction was performed in a disposible UV-Transparent 
cuvette (BrandTech, part# 759215) without stirring at 
37 °C. The absorbance at 405 nm was measured every 5 s 
for 60  s with a UV–Vis spectrophotometer (Nanodrop, 
part# 2000c). The reaction was linear for the first 40 s of 
all reactions tested and the change in the absorbance as 
a function of time was determined using a linear least-
squares fit. The initial reaction velocity was calculated 
using an extinction coefficient of 18,000  M−1  cm−1, as 
specified by the vendor. The experiment was performed 
on different days in biological triplicate. Error bars repre-
sent one standard deviation.
Enzyme‑linked immunosorbent assay (ELISA)
Samples were grown overnight in LB-L media, then 
subcultured 1:100 in LB-L media and grown for 8 h at 
37  °C and 225  rpm. The cultures were pelleted by one 
centrifugation step of 2272×g for 10 min and the super-
natant was passed through a 0.45  μm filter. The wells 
of a 96-well microtiter plate (Santa Cruz Biotechnol-
ogy, Inc., part# sc-204463) was coated with 100  µL of 
a solution of 4 µg mL−1 protective antigen (PA) of the 
anthrax toxin (List Biological Laboratories, part# 171E) 
in 5 mM HEPES, 50 mM NaCl, pH 7.5 covered at 4 °C 
overnight. Liquid was removed by inversion and wells 
were incubated with a 200 µL blocking solution (200 µL 
2% milk, 0.05% TBST) at room temperature for 1  h. 
Liquid was removed by inversion and 100  µL filtered 
culture supernatant was added to the wells. Samples 
were incubated at room temperature for 2 h. Liquid was 
removed by inversion and wells were rinsed with 0.05% 
TBST three times. Next, 100  µL of primary labeling 
solution (1:10,000 dilution of Mouse anti-FLAG anti-
body (Sigma) diluted in 0.05% TBST) was added to the 
wells and incubated 1  h at room temperature. Liquid 
was removed by inversion and wells were rinsed with 
0.05% TBST five times. Then, 100 µL of secondary labe-
ling solution (1:5000 dilution of Goat anti-Mouse IgG 
(H  +  L), HRP conjugate antibodies (Thermo) diluted 
in 0.05% TBST) was added to the wells and incubated 
1 h at room temperature. Liquid was removed by inver-
sion and wells were rinsed with 0.05% TBST five times. 
100  µL of 3,3′,5,5′-Tetramethylbenzidine (TMB) Liq-
uid Substrate (Thermo) was added to the wells and 
incubated for approximately 20  min at room tem-
perature. The reaction was quenched with 100 µL 2 M 
H2SO4. Absorbance at 450  nm was measured using a 
Synergy HTX Multi-Mode Reader spectrophotometer 
(Bio-Tek).
Cysteine alkylation
Filtered supernatant samples were precipitated with 
trichloroacetic acid (20% w/w final concentration) over-
night at 4 °C, washed twice with cold acetone, and dried 
by heating. Dried samples were resuspended in 50  µL 
resuspension buffer (1  M Tris (base), pH 7.5, 3% w/w 
sodium dodecyl sulfate). Resuspension buffer was sup-
plemented with 10  mM tris(2-carboxyethyl)phosphine 
(TCEP) for reduced samples, as necessary. Samples were 
incubated at room temperature for 10 min. Next, 8.8 µL 
of 100  mM 4-acetamido-4′-maleimidylstilbene-2,2′-
disulfonic acid (AMS) was added to samples (final con-
centration is 15  mM), as necessary. Samples to which 
AMS was not added were diluted with equal volume 
distilled water. Samples were incubated at room tem-
perature for 2 h, protected from light. Samples were then 
mixed with Laemmli buffer, boiled, and separated by 
SDS-PAGE, and bands were detected by a western blot, 
as specified above.
Error estimation of Michaelis–Menten model
Error estimation was conducted using Matlab (Math-
works, R2014a). Biological replicates were treated as 
independent samples. Three independent replicates were 
then analyzed for both purified and secreted samples. 
Least-squares minimization was used to fit a modified 
Michaelis-Menten model (Eq. 1) to the measured values 
and determine the parameters kappcat  and KM.
where V0 is the initial reaction rate, [E]T is the total 
enzyme concentration, [S] is the substrate concentration, 
and kappcat  and KM are fitting parameters. To compare the 
parameters from different treatments, a t test (Eq. 2) was 
used where the degrees of freedom was determined by 
the pooled sample size.
where t is the t statistic, β is the fitting parameter of inter-
est (i.e., kappcat  and KM), and Se is the standard error calcu-
lated from the nonlinear regression. A p value of 0.05 was 
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